{"id":"https://openalex.org/W284079080","doi":"https://doi.org/10.1182/blood.v77.10.2109.2109","title":"Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine","display_name":"Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine","publication_year":1991,"publication_date":"1991-05-15","ids":{"openalex":"https://openalex.org/W284079080","doi":"https://doi.org/10.1182/blood.v77.10.2109.2109","mag":"284079080","pmid":"https://pubmed.ncbi.nlm.nih.gov/1709368"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v77.10.2109.2109","doi":"https://doi.org/10.1182/blood.v77.10.2109.2109","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v77.10.2109.2109","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062320910","display_name":"SA Miles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SA Miles","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109570990","display_name":"Mitsuyasu Rt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RT Mitsuyasu","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109053198","display_name":"Julio H. Moreno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Moreno","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109852202","display_name":"Gayle Cocita Baldwin","orcid":"https://orcid.org/0000-0003-1377-6943","observed_orcids":["https://orcid.org/0000-0003-1377-6943"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Baldwin","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060017383","display_name":"N. Kirby Alton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"NK Alton","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113757673","display_name":"LM Souza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Souza","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085812231","display_name":"J A Glaspy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JA Glaspy","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":17.8679,"has_fulltext":false,"cited_by_count":133,"citation_normalized_percentile":{"value":0.99509962,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"77","issue":"10","first_page":"2109","last_page":"2117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5131999850273132,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5131999850273132,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.3955000042915344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.05350000038743019,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9089999794960022},{"id":"https://openalex.org/keywords/erythropoietin","display_name":"erythropoietin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/aids","display_name":"AIDS","score":0.640999972820282},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8700000047683716},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hematopoietic-growth-factors","display_name":"hematopoietic growth factors","score":0.6909999847412109},{"id":"https://openalex.org/keywords/hiv-p24-antigen","display_name":"HIV p24 antigen","score":0.7039999961853027},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.75},{"id":"https://openalex.org/keywords/ganciclovir","display_name":"ganciclovir","score":0.8109999895095825},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.671999990940094},{"id":"https://openalex.org/keywords/hematopoietic-recovery","display_name":"hematopoietic recovery","score":0.5509999990463257},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.8458870649337769},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8174442648887634},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.809719979763031},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.6506437063217163},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.6190537214279175},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5799387693405151},{"id":"https://openalex.org/C74133956","wikidata":"https://www.wikidata.org/wiki/Q4669824","display_name":"Absolute neutrophil count","level":4,"score":0.5517216324806213},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5175044536590576},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5129773020744324},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.47317272424697876},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.4515126049518585},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.43312007188796997},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41879743337631226},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.41169583797454834},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3093557357788086},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.13148686289787292},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.08662360906600952}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D001772","descriptor_name":"Blood Cell Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009894","descriptor_name":"Opportunistic Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014758","descriptor_name":"Viral Core Proteins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015683","descriptor_name":"Gene Products, gag","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D015774","descriptor_name":"Ganciclovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016655","descriptor_name":"HIV Core Protein p24","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v77.10.2109.2109","doi":"https://doi.org/10.1182/blood.v77.10.2109.2109","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v77.10.2109.2109","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v77.10.2109.bloodjournal77102109","doi":"https://doi.org/10.1182/blood.v77.10.2109.bloodjournal77102109","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v77.10.2109.bloodjournal77102109","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:1709368","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1709368","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1594575005","https://openalex.org/W1987884524","https://openalex.org/W2011406016","https://openalex.org/W2014195698","https://openalex.org/W2054620412","https://openalex.org/W2059865376","https://openalex.org/W2062555652","https://openalex.org/W2069095530","https://openalex.org/W2086462809","https://openalex.org/W2092368843","https://openalex.org/W2112852474","https://openalex.org/W2122064095","https://openalex.org/W2160871721","https://openalex.org/W2307541432","https://openalex.org/W2317007280","https://openalex.org/W2323021547","https://openalex.org/W2330207218","https://openalex.org/W2331565502","https://openalex.org/W2333399282","https://openalex.org/W2400195285","https://openalex.org/W2411414873"],"related_works":["https://openalex.org/W2053119406","https://openalex.org/W2011241032","https://openalex.org/W1686460","https://openalex.org/W2022953223","https://openalex.org/W2332889373","https://openalex.org/W2394592635","https://openalex.org/W2068961889","https://openalex.org/W2088046163","https://openalex.org/W2519771036","https://openalex.org/W2404269502"],"abstract_inverted_index":{"Twenty-two":[0],"patients":[1,32,88,130,172,177,183,284,329],"with":[2,17,105,134,276,289,306],"acquired":[3],"immunodeficiency":[4],"syndrome":[5],"(AIDS)":[6],"or":[7,233,265,343],"severe":[8],"AIDS-related":[9],"complex":[10],"and":[11,23,35,60,72,100,115,151,158,181,201,203,238,247,268,308,314],"multilineage":[12],"hematopoietic":[13],"defects":[14],"were":[15,33,89,162,236,286],"treated":[16,288],"recombinant":[18],"granulocyte":[19],"colony-stimulating":[20],"factor":[21],"(G-CSF)":[22],"erythropoietin":[24],"(EPO)":[25],"in":[26,139,142,149,168,196,199,209,282,327],"a":[27,135,197],"phase":[28],"I/II":[29],"trial.":[30],"All":[31,128],"neutropenic":[34],"anemic":[36],"after":[37],"withdrawal":[38],"of":[39,79,82,87,93,123,187,193,206,211,216,231,298,316,324,331,335,340,346],"all":[40,169],"bone":[41,159],"marrow-suppressive":[42],"drugs.":[43],"Daily,":[44],"G-CSF":[45,99,133,264,267,307],"was":[46,58,67,84,103,125],"subcutaneously":[47],"self-administered":[48],"until":[49,76],"an":[50,77,110],"absolute":[51],"neutrophil":[52],"count":[53],"(ANC)":[54],"greater":[55,112,117],"than":[56,113,118,144],"6,000/microL":[57],"achieved":[59],"maintained":[61],"for":[62,250],"2":[63,145],"weeks.":[64,146,175],"Subcutaneous":[65],"EPO":[66,101,164,269,309],"added":[68],"to":[69,95,108,132],"the":[70,73,204,212,219,226,296,312,322,332,344],"regimen":[71],"dose":[74,106,122,242],"increased":[75,166],"increase":[78,138],"15":[80],"g/L":[81],"hemoglobin":[83,116,167,202],"observed.":[85],"Groups":[86],"administered":[90],"increasing":[91],"doses":[92],"zidovudine":[94,124,188,194,277,326,336],"determine":[96],"their":[97],"tolerance.":[98],"therapy":[102,165,305,319],"continued":[104],"modification":[107],"maintain":[109],"ANC":[111],"1,500/microL":[114],"100":[119],"g/L.":[120],"The":[121,191],"not":[126,240,260],"altered.":[127],"22":[129],"responded":[131],"mean":[136],"10-fold":[137],"neutrophils":[140],"occurring":[141],"less":[143],"Significant":[147],"increases":[148],"CD4":[150],"CD8":[152],"cell":[153],"number,":[154],"lymphocyte":[155,248],"proliferative":[156],"response,":[157],"marrow":[160],"cellularity":[161],"seen.":[163],"20":[170,213],"evaluable":[171],"within":[173],"8":[174],"Sixteen":[176],"received":[178,184],"1,000":[179],"mg":[180,186],"four":[182],"1,500":[185],"per":[189],"day.":[190],"reinstitution":[192],"resulted":[195],"decline":[198],"reticulocytes":[200],"reappearance":[205],"transfusion":[207],"requirements":[208],"eight":[210],"patients,":[214],"six":[215],"whom":[217],"had":[218,225],"study":[220,227],"medications":[221,228],"stopped.":[222],"No":[223],"patient":[224],"stopped":[229],"because":[230],"neutropenia":[232,313],"thrombocytopenia.":[234],"Toxicities":[235],"mild":[237],"did":[239,259],"require":[241],"modifications.":[243],"Limiting":[244],"dilution":[245],"plasma":[246],"co-cultures":[249],"HIV":[251,271,341],"as":[252,254],"well":[253],"serum":[255],"p24":[256,272],"antigen":[257,273],"levels":[258],"change":[261],"significantly":[262,275],"during":[263],"combined":[266,304],"therapy.":[270,278],"decreased":[274],"Opportunistic":[279],"infections":[280],"occurred":[281],"14":[283],"but":[285],"successfully":[287],"myelosuppressive":[290],"antimicrobial":[291],"agents,":[292],"including":[293],"ganciclovir,":[294],"without":[295,337],"development":[297],"neutropenia.":[299],"These":[300],"results":[301],"suggest":[302],"that":[303],"may":[310,320],"improve":[311],"anemia":[315],"AIDS.":[317],"Combined":[318],"allow":[321],"resumption":[323],"full-dose":[325],"most":[328],"intolerant":[330],"hematologic":[333],"effects":[334],"apparent":[338],"alteration":[339],"expression":[342],"efficacy":[345],"zidovudine.":[347]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}